15
Participants
Start Date
March 30, 2021
Primary Completion Date
August 29, 2023
Study Completion Date
August 29, 2023
Advanced Magnetic Resonance Imaging
Undergo advanced MRI
Conventional Magnetic Resonance Imaging
Undergo conventional MRI
Gadolinium-Chelate
Contrast agent
Iopamidol
Contrast agent
M D Anderson Cancer Center, Houston
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER